Treść książki
Przejdź do opcji czytnikaPrzejdź do nawigacjiPrzejdź do informacjiPrzejdź do stopki
16.TanJ,ThiboutotD,PoppG,etal.Randomizedphase3evaluationoftrifarotene50μg/gcreamtre-
atmentofmoderatefacialandtruncalacne.JAmAcadDermatol.2019;80:1691-9.
17.TanghettiEA,WerschlerWP,LainT,etal.Tazarotene0.045%LotionforOnce-DailyTreatmentof
Moderate-to-SevereAcneVulgaris:ResultsfromTwoPhase3Trials.JDrugsDermatol.2020;19:70-7.
18.MarahattaS,ShresthaU.Hospitalprevalenceandcausesofnon-adherencetoacnetreatment:A
reportfromNepal.OurDermatolOnline.2021;12:251-6.
19.YaleS,StefankoN,McCarthyP,etal.Severemethemoglobinemiaduetotopicaldapsonemisuse
inateenagegirl.PediatrDermatol.2020;37:377-8.
20.TanghettiE,HarperJ,BaldwinH,etalOnce-DailyTopicalDapsoneGel,7.5%:EfectiveforAcne
VulgarisRegardlessofBaselineLesionCount,WithSuperiorEfcacyinFemales.JDrugsDermatol.
2018;17:1192-8.
21.MooreA,LingM,BuckoA,etal.EfcacyandSafetyofSubantimicrobialDose,Modified-Release
Doxycycline40mgVersusDoxycycline100mgVersusPlaceboforthetreatmentofInflammatoryLe-
sionsinModerateandSevereAcne:ARandomized,Double-Blinded,ControlledStudy.JDrugsDermatol.
2015;14:581-6.
22.SanjelK,ZhangXM.Progressofdiferenttreatmentmodalitiestolimittheuseofantibioticsinthe
treatmentofacne.OurDermatolOnline.2022;13:92-7.
23.MooreA,GreenLJ,BruceS,etal.Once-DailyOralSarecycline1.5mg/kg/dayIsEfectiveforMo-
deratetoSevereAcneVulgaris:ResultsfromTwoIdenticallyDesigned,Phase3,Randomized,Double-
-BlindClinicalTrials.JDrugsDermatol.2018;17:987-96.
24.NguyenTA,KrakowskiAC.The"HeartSign”:AnEarlyIndicatorofDose-DependentDoxycycline-
-InducedPhototoxicity.PediatrDermatol.2016;33:e69-71.
25.Hellmann-RegenJ,HerzogI,FischerN,etal.Dotetracyclinesanderythromycinexertanti-acne
efectsbyinhibitionofP450-mediateddegradationofretinoicacid?.ExpDermatol.2014;23:290-3.
26.Traitementdel’acnéparvoielocaleetgénérale(recommandations).2015.http://www.sfdermato.
org/media/pdf/recommandation/algorithme-54ac60356d1b9584a71ccaac92cf3724.pdf
27.MillerIM,EcheverriaB,TorreloA,etal.Infantileacnetreatedwithoralisotretinoin.PediatrDer-
matol.2013;30:513-8.
28.DrenoB,BlouinE.Acne,pregnantwomenandzincsalts:aliteraturereview.AnnDermatolVene-
reol.2008;135:27-33.
29.RobertsE,NowsheenS,DavisD,etal.Useofspironolactonetotreatacneinadolescentfemales.
PediatricDermatol.2020;00:1-5.
30.KręgielM,ŻuchowskaA,TomaszewskaK,etal.Acnefulminansinthecourseoforalisotretinoin
treatment.Presentationofcases.OurDermatolOnline.2017;8:210-4.
31.IncelUysalP.Rapid-onsetoralisotretinoin-inducedacnefulminanswithoutsystemicsymptomsin
amaleadolescent.OurDermatolOnline.2021;12:417-8.
14
